Metal ion binding to human hemopexin.
Binding of divalent metal ions to human hemopexin (Hx) purified by a new protocol has been characterized by metal ion affinity chromatography and potentiometric titration in the presence and absence of bound protoheme IX. ApoHx was retained by variously charged metal affinity chelate resins in the following order: Ni(2+) > Cu(2+) > Co(2+) > Zn(2+) > Mn(2+). The Hx-heme complex exhibited similar behavior except the order of retention of the complex on Zn(2+)- and Co(2+)-charged columns was reversed. One-dimensional (1)H NMR of apoHx in the presence of Ni(2+) implicates at least two His residues and possibly an Asp, Glu, or Met residue in Ni(2+) binding. Potentiometric titrations establish that apoHx possesses more than two metal ion binding sites and that the capacity and/or affinity for metal ion binding is diminished when heme binds. For most metal ions that have been studied, potentiometric data did not fit to binding isotherms that assume one or two independent binding sites. For Mn(2+), however, these data were consistent with a high-affinity site [K(A) = (15 +/- 3) x 10(6) M(-)(1)] and a low-affinity site (K(A) <or= 2 x10(3) M(-)(1)). Binding of Cu(2+) and Zn(2+) to the Hx-heme complex produced significant changes in the Soret-CD spectrum of the Hx-heme complex that were reversed with addition of EDTA. Possibly, these metal ions bind near the heme binding site and perturb the electronic environment of the heme, or their binding induces exchange of one axial His ligand to the heme iron with another adjacent His residue. A possible role for Hx in the maintenance of metal ion homeostasis is discussed.
Mauk
Marcia R
MR
Department of Biochemistry and Molecular Biology and Centre for Blood Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Rosell
Federico I
FI
Lelj-Garolla
Barbara
B
Moore
Geoffrey R
GR
Mauk
A Grant
AG
D000818:Animals; D001059:Apoproteins / Q000737:chemistry / Q000378:metabolism; D002413:Cations, Divalent; D002499:Centrifugation, Density Gradient; D002614:Chelating Agents / Q000737:chemistry / Q000378:metabolism; D002942:Circular Dichroism; D003300:Copper / Q000737:chemistry / Q000378:metabolism; D006418:Heme / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D006466:Hemopexin / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007475:Ion Exchange Resins / Q000737:chemistry / Q000378:metabolism; D019216:Metals, Heavy / Q000737:chemistry* / Q000378:metabolism; D009532:Nickel / Q000737:chemistry / Q000378:metabolism; D019906:Nuclear Magnetic Resonance, Biomolecular; D011199:Potentiometry; D011485:Protein Binding; D012756:Sheep; D013056:Spectrophotometry, Ultraviolet; D015032:Zinc / Q000737:chemistry / Q000378:metabolism
D001059:Apoproteins; D002413:Cations, Divalent; D002614:Chelating Agents; D007475:Ion Exchange Resins; D019216:Metals, Heavy; C435883:heme b(595); D006418:Heme; D003300:Copper; D009532:Nickel; D006466:Hemopexin; D015032:Zinc